Bajaj Finserv Healthcare IDCW Reinvest Direct Plan
SIP amount
Min. ₹500
Lumpsum amount
Min. ₹500

Bajaj Finserv Healthcare IDCW Reinvest Direct Plan

NAV
₹9.9430
+0.06%
(20 Aug)
AUM
341 Cr
TER
0.67%
Risk
Very High Risk
Insights
Asset Under Management (AUM) is in the bottom 25% of comparable funds
In beta. Send feedback here.
Compare with other fund
1Y
-6.5%
-6.5%
-6.5%
-7.0%
NA
3Y
+33.2%
+33.2%
+33.2%
+32.4%
NA
5Y
+30.9%
+30.9%
+30.9%
+29.2%
NA
ALL
+11.9%
+11.9%
+11.9%
+16.5%
-0.6%
VOL
20.2%
20.2%
20.2%
20.3%
14.9%
TER
0.8%
0.8%
0.8%
0.9%
0.7%
AUM
₹5,278 Cr
₹5,278 Cr
₹5,278 Cr
₹1,391 Cr
₹341 Cr
INFO
0.59
0.59
0.59
0.82
-0.04
See fund holdings as of 31st Jul
Top holdings
Divi's Laboratories Ltd
7.9%
Sun Pharmaceuticals Industries Ltd
7.5%
Apollo Hospitals Enterprise Ltd
6.0%
Cipla Ltd
5.3%
Biocon Ltd
3.8%
Glenmark Pharmaceuticals Ltd
3.4%
Emcure Pharmaceuticals Ltd
3.4%
Dr Reddy's Laboratories Ltd
3.4%
Syngene International Ltd
3.2%
Fortis Healthcare Ltd
3.2%
Top industry exposure
Healthcare
87.1%
Consumer Defensive
7.5%
Basic Materials
1.6%
Financial Services
0.5%
Other information
Minimum SIP
₹500
Minimum lumpsum
₹500
Additional lumpsum
₹100
Portfolio turnover
-
Lock-in period
-
Exit load
• 1% for redemption within 90 days
Fund objective
The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
Fund manager(s)
Nimesh Chandan
Siddharth Chaudhary
Sorbh Gupta

FAQs